After Buying Vetnex, Pfizer Invests $40 Million To Set Up Discovery Research Center For Animal Health Drugs In India
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - When Pfizer's $3.5 billion animal health unit made a resolute bid last June to acquire Vetnex - a small but growing Indian veterinary care company - it took industry watchers by surprise, but a well-crafted, elaborate plan was stealthily being executed
You may also be interested in...
Pfizer Inks Animal Health JV With Chinese Company Jilin Guoyuan
Pfizer Inc. announced a joint venture Sept. 8 with China's Jilin Guoyuan Animal Heatlh Company, Ltd. to develop, manufacture and distribute animal health vaccines in China
Pfizer Inks Animal Health JV With Chinese Company Jilin Guoyuan
Pfizer Inc. announced a joint venture Sept. 8 with China's Jilin Guoyuan Animal Heatlh Company, Ltd. to develop, manufacture and distribute animal health vaccines in China
India's RFCL Braves Into The Stronghold Of MNCs With High-end Diagnostics; Will It Become The Next Takeover Candidate?
MUMBAI - Having identified a distinct cost advantage over its bigger Western counterparts, RFCL - India's largest in-vitro diagnostics and laboratory solutions firm - is branching out into the manufacture of high-end diagnostic products used for immunoassays, a range of molecular diagnostic kits and theranostics, bringing it a step closer toward personalized medicine